MBX Biosciences is a clinical-stage biopharmaceutical company focused on discovery, development, and commercialization of precision peptide therapies for endocrine and metabolic disorders. Using its proprietary Precision Endocrine Peptide (PEP) platform, the company develops candidates including canvuparatide (MBX 2109) for chronic hypoparathyroidism, MBX 4291 (a GLP-1/GIP co-agonist) for obesity, and imapextide (MBX 1416) for post-bariatric hypoglycemia, targeting extended time-action profiles and low peak-to-trough ratios.
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001193125-26-103121 | EDGAR | 107K words |
| 2025-03-17 | 2024-12-31 | 0000950170-25-039838 | EDGAR | 106K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001193125-26-336849 | EDGAR | 22K words |
| 2025-11-06 | 2025-09-30 | 0001193125-25-268148 | EDGAR | 24K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-104619 | EDGAR | 22K words |
| 2025-05-12 | 2025-03-31 | 0000950170-25-068602 | EDGAR | 19K words |
| 2024-11-07 | 2024-09-30 | 0000950170-24-122840 | EDGAR | 74K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-27 | 0001193125-26-369674 | EDGAR | 2K words |
| 2026-08-06 | 0001193125-26-336841 | EDGAR | 2K words |
| 2026-07-13 | 0001193125-26-302098 | EDGAR | 2K words |
| 2026-03-12 | 0001193125-26-103118 | EDGAR | 3K words |
| 2026-03-09 | 0001193125-26-097611 | EDGAR | 1K words |
| 2026-02-27 | 0001193125-26-079286 | EDGAR | 52K words |
| 2026-02-05 | 0001193125-26-039475 | EDGAR | 1K words |
| 2026-01-22 | 0001193125-26-018700 | EDGAR | 1K words |
| 2026-01-12 | 0001193125-26-009642 | EDGAR | 2K words |
| 2025-11-06 | 0001193125-25-268146 | EDGAR | 3K words |
37 total filings indexed. 20 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001776111 |
| Ticker | MBX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.mbxbio.com |
| Listed | 2024-09-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MBX (~200 tokens, structured JSON with cryptographic provenance)